Howard Levy, MD, PhD is co-editor-in-chief of GeneFacts. He was a member of the review board for the NIH Office of Rare Diseases Research Collaboration, Education and Test Translation Program for Rare Genetic Disease and currently sits on the executive committee of the Johns Hopkins/NIH Genetic Counseling Training program.
What exciting developments in genetic testing should we expect to see in 2015? “This year’s cutting edge research and discoveries are likely several years removed from impacting most people’s lives. I think pharmacogenetics and cancer genetics are ready for more widespread use in the near future—not necessarily this year, but soon. Not everyone is convinced yet, but there is growing evidence that pharmacogenetic testing can improve the safety and efficacy of at least some medications. In oncology, more effective and better tolerated therapies that target specific genetic changes within cancer cells are becoming available for increasingly more tumor types.”
Jenni Whalen is the Executive Assistant of Editorial at Upworthy. She was previously MedTech Boston's Managing Editor and has an MS in Journalism from Boston University, as well as a BA in Psychology from Bucknell University. Whalen has written for Greatist, Boston magazine, AZ Central Healthy Living and the New England Journal of Medicine, among other places. She has also worked as a conference planner, ghost writer, researcher and content developer.
Send this to a friend